Verdict: Side-by-side breakdown using the Bull Rankings model. CNS scored 75.0, FHI scored 80.0 — FHI leads.
Compare another set
CNS
Cohen & Steers, Inc.
Asset Management · Financial strength
77.1Fin
$68.86 · $3.5B
fundamentals as of
Strength gap
11.6
FHI leads
FHI
Federated Hermes, Inc.
Asset Management · Financial strength
88.7Fin
$54.15 · $4.0B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
CheapestFHI10.1x
Fastest growthFHI+10.3%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
Fundamentals, head-to-head
CNS
FHI
+7.7%B
Rev
+10.3%B
21.2xC
P/E
10.1xA-
27.3%A-
ROE
31.1%A
6.02D
P/B
3.20C
3.9%B+
Yield
2.5%B
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
The companies
CNSCohen & Steers, Inc.
Asset Management · $68.86 · beta 1.22
Why now
Asset Management · market cap $3.5b. Down 20% from 52-week high of $86.56 — deep drawdown territory. 3 sell-side analysts rate this a Hold with a mean 1-yr target of $74.67 (implying +8% upside).
Moat
Net margin 29% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 27% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which.
Risk
Balance-sheet financial — book value, net interest margin, and credit loss provisions are the lever points; a rates regime change or a deterioration in the loan book moves the stock more than EPS does.
FHIFederated Hermes, Inc.
Asset Management · $54.15 · beta 0.64
Why now
Asset Management · market cap $4.0b. 19% off the 52-week high of $67.20. Revenue growing +10%, comfortably above the S&P median. 7 sell-side analysts rate this a Hold with a mean 1-yr target of $59.43 (implying +10% upside).
Moat
Net margin 21% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 31% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which.
Risk
Balance-sheet financial — book value, net interest margin, and credit loss provisions are the lever points; a rates regime change or a deterioration in the loan book moves the stock more than EPS does.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Common questions
Is FHI or CNS the better stock?
FHI scores higher: FHI 80.0, CNS 75.0 out of 100 on the Bull Rankings quality-growth score, which blends business quality, growth and valuation into one number. A higher score means a stronger business at a more reasonable price — it is not a price target or a recommendation.
How are FHI and CNS scored?
Each carries the same 0–100 quality-growth score used everywhere on the site, built from three pillars — quality (profitability and returns on capital), growth (revenue and earnings), and value (what you pay for them) — combined as a geometric mean, so a weak pillar cannot be papered over by a strong one.
How current is this comparison?
The whole universe is re-scored every trading day after the US market close, so the scores and fundamentals here reflect the latest published edition.